PDB Short entry for 1LSJ HEADER OXIDOREDUCTASE 17-MAY-02 1LSJ TITLE CRYSTAL STRUCTURE OF THE E110Q MUTANT OF L-3-HYDROXYACYL-COA TITLE 2 DEHYDROGENASE IN COMPLEX WITH NAD COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3-HYDROXYACYL-COA DEHYDROGENASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: L-3-HYDROXYACYL-COA DEHYDROGENASE, SHORT CHAIN 3- COMPND 5 HYDROXYACYL-COA DEHYDROGENASE, HCDH; COMPND 6 EC: 1.1.1.35; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HCDH; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS ROSSMANN FOLD, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR J.J.BARYCKI,L.J.BANASZAK REVDAT 5 14-FEB-24 1LSJ 1 REMARK REVDAT 4 27-OCT-21 1LSJ 1 REMARK SEQADV REVDAT 3 04-APR-18 1LSJ 1 REMARK REVDAT 2 24-FEB-09 1LSJ 1 VERSN REVDAT 1 03-FEB-04 1LSJ 0 JRNL AUTH J.J.BARYCKI,L.J.BANASZAK JRNL TITL CRYSTAL STRUCTURE OF THE E110Q MUTANT OF L-3-HYDROXYACYL-COA JRNL TITL 2 DEHYDROGENASE IN COMPLEX WITH NAD JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.J.BARYCKI,L.K.O'BRIEN,J.M.BRATT,R.ZHANG,R.SANISHVILI, REMARK 1 AUTH 2 A.W.STRAUSS,L.J.BANASZAK REMARK 1 TITL BIOCHEMICAL CHARACTERIZATION AND CRYSTAL STRUCTURE REMARK 1 TITL 2 DETERMINATION OF HUMAN HEART SHORT CHAIN L-3-HYDROXYACYL-COA REMARK 1 TITL 3 DEHYDROGENASE PROVIDE INSIGHTS INTO CATALYTIC MECHANISM REMARK 1 REF BIOCHEMISTRY V. 38 5786 1999 REMARK 1 REFN ISSN 0006-2960 REMARK 1 DOI 10.1021/BI9829027 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 25678 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1236 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4009 REMARK 3 BIN R VALUE (WORKING SET) : 0.2720 REMARK 3 BIN FREE R VALUE : 0.3320 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 204 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.023 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4486 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 88 REMARK 3 SOLVENT ATOMS : 159 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.32 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.43 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.840 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.140 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.950 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.660 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.580 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 24.11 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NAD_MOD.PARAM REMARK 3 PARAMETER FILE 4 : CAA_IDEAL_50.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NAD.TOP REMARK 3 TOPOLOGY FILE 4 : CAA.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1LSJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-MAY-02. REMARK 100 THE DEPOSITION ID IS D_1000016242. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUN-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTAL CLEAR / D*TREK, REMARK 200 CRYSTALCLEAR D*TREK (MSC/RIGAKU) REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR D*TREK (MSC/RIGAKU) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25717 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 28.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 4.770 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.75 REMARK 200 R MERGE FOR SHELL (I) : 0.23100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 7.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 3HAD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM N-[2-ACETAMIDO]-2-IMINODIACETIC REMARK 280 ACID WITHIN THE PRECIPITANT RANGE OF 14% TO 19% POLYETHYLENE REMARK 280 GLYCOL 4000, PH 6.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.01000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 84.25250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.97500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 84.25250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.01000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.97500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICALLY RELEVANT DIMER CONTAINED WITHIN THE ASYMMETRIC REMARK 300 UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25110 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 SER A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 THR A 5 REMARK 465 ALA A 6 REMARK 465 SER A 7 REMARK 465 ALA A 8 REMARK 465 SER A 9 REMARK 465 ALA A 10 REMARK 465 LYS A 11 REMARK 465 SER B 1 REMARK 465 SER B 2 REMARK 465 SER B 3 REMARK 465 SER B 4 REMARK 465 THR B 5 REMARK 465 ALA B 6 REMARK 465 SER B 7 REMARK 465 ALA B 8 REMARK 465 SER B 9 REMARK 465 ALA B 10 REMARK 465 LYS B 11 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 68 31.90 -89.81 REMARK 500 LYS A 69 -46.36 -155.41 REMARK 500 ASN A 73 73.05 -175.18 REMARK 500 ILE A 88 74.46 -108.08 REMARK 500 ILE A 108 -165.15 -113.51 REMARK 500 GLN A 110 66.15 -63.55 REMARK 500 ALA A 126 156.68 -49.35 REMARK 500 THR A 130 131.38 -36.15 REMARK 500 PHE A 205 -132.99 53.02 REMARK 500 ILE A 206 -77.53 -87.92 REMARK 500 ASP A 269 50.07 -161.66 REMARK 500 ALA A 270 -32.42 -36.11 REMARK 500 ASN B 73 69.74 -156.87 REMARK 500 SER B 100 31.36 -140.99 REMARK 500 VAL B 109 135.59 -38.16 REMARK 500 GLN B 110 46.59 -72.09 REMARK 500 PHE B 205 -104.81 54.62 REMARK 500 ILE B 206 -64.75 -122.04 REMARK 500 LYS B 289 79.99 -110.03 REMARK 500 LYS B 293 40.37 -69.56 REMARK 500 THR B 294 -25.75 -165.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 350 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 750 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3HAD RELATED DB: PDB REMARK 900 3HAD IS THE WILD-TYPE L-HYDROXYACYL-COA DEHYDROGENASE IN COMPLEX REMARK 900 WITH NAD REMARK 900 RELATED ID: 1LSO RELATED DB: PDB REMARK 900 1LSO IS THE CRYSTAL STRUCTURE OF THE S137A MUTANT OF L-3- REMARK 900 HYDROXYACYL-COA DEHYDROGENASE IN COMPLEX WITH NAD DBREF 1LSJ A 1 302 UNP Q16836 HCDH_HUMAN 7 308 DBREF 1LSJ B 1 302 UNP Q16836 HCDH_HUMAN 7 308 SEQADV 1LSJ GLN A 110 UNP Q16836 GLU 116 ENGINEERED MUTATION SEQADV 1LSJ GLN B 110 UNP Q16836 GLU 116 ENGINEERED MUTATION SEQRES 1 A 302 SER SER SER SER THR ALA SER ALA SER ALA LYS LYS ILE SEQRES 2 A 302 ILE VAL LYS HIS VAL THR VAL ILE GLY GLY GLY LEU MET SEQRES 3 A 302 GLY ALA GLY ILE ALA GLN VAL ALA ALA ALA THR GLY HIS SEQRES 4 A 302 THR VAL VAL LEU VAL ASP GLN THR GLU ASP ILE LEU ALA SEQRES 5 A 302 LYS SER LYS LYS GLY ILE GLU GLU SER LEU ARG LYS VAL SEQRES 6 A 302 ALA LYS LYS LYS PHE ALA GLU ASN PRO LYS ALA GLY ASP SEQRES 7 A 302 GLU PHE VAL GLU LYS THR LEU SER THR ILE ALA THR SER SEQRES 8 A 302 THR ASP ALA ALA SER VAL VAL HIS SER THR ASP LEU VAL SEQRES 9 A 302 VAL GLU ALA ILE VAL GLN ASN LEU LYS VAL LYS ASN GLU SEQRES 10 A 302 LEU PHE LYS ARG LEU ASP LYS PHE ALA ALA GLU HIS THR SEQRES 11 A 302 ILE PHE ALA SER ASN THR SER SER LEU GLN ILE THR SER SEQRES 12 A 302 ILE ALA ASN ALA THR THR ARG GLN ASP ARG PHE ALA GLY SEQRES 13 A 302 LEU HIS PHE PHE ASN PRO VAL PRO VAL MET LYS LEU VAL SEQRES 14 A 302 GLU VAL ILE LYS THR PRO MET THR SER GLN LYS THR PHE SEQRES 15 A 302 GLU SER LEU VAL ASP PHE SER LYS ALA LEU GLY LYS HIS SEQRES 16 A 302 PRO VAL SER CYS LYS ASP THR PRO GLY PHE ILE VAL ASN SEQRES 17 A 302 ARG LEU LEU VAL PRO TYR LEU MET GLU ALA ILE ARG LEU SEQRES 18 A 302 TYR GLU ARG GLY ASP ALA SER LYS GLU ASP ILE ASP THR SEQRES 19 A 302 ALA MET LYS LEU GLY ALA GLY TYR PRO MET GLY PRO PHE SEQRES 20 A 302 GLU LEU LEU ASP TYR VAL GLY LEU ASP THR THR LYS PHE SEQRES 21 A 302 ILE VAL ASP GLY TRP HIS GLU MET ASP ALA GLU ASN PRO SEQRES 22 A 302 LEU HIS GLN PRO SER PRO SER LEU ASN LYS LEU VAL ALA SEQRES 23 A 302 GLU ASN LYS PHE GLY LYS LYS THR GLY GLU GLY PHE TYR SEQRES 24 A 302 LYS TYR LYS SEQRES 1 B 302 SER SER SER SER THR ALA SER ALA SER ALA LYS LYS ILE SEQRES 2 B 302 ILE VAL LYS HIS VAL THR VAL ILE GLY GLY GLY LEU MET SEQRES 3 B 302 GLY ALA GLY ILE ALA GLN VAL ALA ALA ALA THR GLY HIS SEQRES 4 B 302 THR VAL VAL LEU VAL ASP GLN THR GLU ASP ILE LEU ALA SEQRES 5 B 302 LYS SER LYS LYS GLY ILE GLU GLU SER LEU ARG LYS VAL SEQRES 6 B 302 ALA LYS LYS LYS PHE ALA GLU ASN PRO LYS ALA GLY ASP SEQRES 7 B 302 GLU PHE VAL GLU LYS THR LEU SER THR ILE ALA THR SER SEQRES 8 B 302 THR ASP ALA ALA SER VAL VAL HIS SER THR ASP LEU VAL SEQRES 9 B 302 VAL GLU ALA ILE VAL GLN ASN LEU LYS VAL LYS ASN GLU SEQRES 10 B 302 LEU PHE LYS ARG LEU ASP LYS PHE ALA ALA GLU HIS THR SEQRES 11 B 302 ILE PHE ALA SER ASN THR SER SER LEU GLN ILE THR SER SEQRES 12 B 302 ILE ALA ASN ALA THR THR ARG GLN ASP ARG PHE ALA GLY SEQRES 13 B 302 LEU HIS PHE PHE ASN PRO VAL PRO VAL MET LYS LEU VAL SEQRES 14 B 302 GLU VAL ILE LYS THR PRO MET THR SER GLN LYS THR PHE SEQRES 15 B 302 GLU SER LEU VAL ASP PHE SER LYS ALA LEU GLY LYS HIS SEQRES 16 B 302 PRO VAL SER CYS LYS ASP THR PRO GLY PHE ILE VAL ASN SEQRES 17 B 302 ARG LEU LEU VAL PRO TYR LEU MET GLU ALA ILE ARG LEU SEQRES 18 B 302 TYR GLU ARG GLY ASP ALA SER LYS GLU ASP ILE ASP THR SEQRES 19 B 302 ALA MET LYS LEU GLY ALA GLY TYR PRO MET GLY PRO PHE SEQRES 20 B 302 GLU LEU LEU ASP TYR VAL GLY LEU ASP THR THR LYS PHE SEQRES 21 B 302 ILE VAL ASP GLY TRP HIS GLU MET ASP ALA GLU ASN PRO SEQRES 22 B 302 LEU HIS GLN PRO SER PRO SER LEU ASN LYS LEU VAL ALA SEQRES 23 B 302 GLU ASN LYS PHE GLY LYS LYS THR GLY GLU GLY PHE TYR SEQRES 24 B 302 LYS TYR LYS HET NAD A 350 44 HET NAD B 750 44 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE FORMUL 3 NAD 2(C21 H27 N7 O14 P2) FORMUL 5 HOH *159(H2 O) HELIX 1 1 GLY A 24 THR A 37 1 14 HELIX 2 2 THR A 47 LYS A 68 1 22 HELIX 3 3 ASN A 73 THR A 87 1 15 HELIX 4 4 ASP A 93 THR A 101 5 9 HELIX 5 5 ASN A 111 ALA A 126 1 16 HELIX 6 6 GLN A 140 ASN A 146 1 7 HELIX 7 7 ARG A 150 ASP A 152 5 3 HELIX 8 8 SER A 178 LEU A 192 1 15 HELIX 9 9 ILE A 206 ARG A 224 1 19 HELIX 10 10 SER A 228 GLY A 241 1 14 HELIX 11 11 GLY A 245 GLY A 254 1 10 HELIX 12 12 GLY A 254 MET A 268 1 15 HELIX 13 13 ASN A 272 GLN A 276 5 5 HELIX 14 14 SER A 278 GLU A 287 1 10 HELIX 15 15 GLY A 291 GLY A 295 5 5 HELIX 16 16 GLY B 24 THR B 37 1 14 HELIX 17 17 THR B 47 PHE B 70 1 24 HELIX 18 18 ASN B 73 SER B 86 1 14 HELIX 19 19 ASP B 93 VAL B 98 1 6 HELIX 20 20 HIS B 99 THR B 101 5 3 HELIX 21 21 ASN B 111 LYS B 124 1 14 HELIX 22 22 GLN B 140 ASN B 146 1 7 HELIX 23 23 ARG B 150 ASP B 152 5 3 HELIX 24 24 SER B 178 LEU B 192 1 15 HELIX 25 25 ILE B 206 ARG B 224 1 19 HELIX 26 26 SER B 228 GLY B 241 1 14 HELIX 27 27 GLY B 245 GLY B 254 1 10 HELIX 28 28 GLY B 254 ASP B 269 1 16 HELIX 29 29 ASN B 272 GLN B 276 5 5 HELIX 30 30 SER B 278 GLU B 287 1 10 SHEET 1 A 8 ILE A 88 SER A 91 0 SHEET 2 A 8 THR A 40 VAL A 44 1 N LEU A 43 O ALA A 89 SHEET 3 A 8 HIS A 17 ILE A 21 1 N VAL A 18 O THR A 40 SHEET 4 A 8 LEU A 103 GLU A 106 1 O LEU A 103 N THR A 19 SHEET 5 A 8 ILE A 131 SER A 134 1 O ALA A 133 N VAL A 104 SHEET 6 A 8 PHE A 154 PHE A 159 1 O ALA A 155 N PHE A 132 SHEET 7 A 8 LEU A 168 LYS A 173 -1 O GLU A 170 N HIS A 158 SHEET 8 A 8 HIS A 195 LYS A 200 1 O VAL A 197 N VAL A 171 SHEET 1 B 8 ILE B 88 SER B 91 0 SHEET 2 B 8 THR B 40 VAL B 44 1 N VAL B 41 O ALA B 89 SHEET 3 B 8 HIS B 17 ILE B 21 1 N VAL B 20 O VAL B 44 SHEET 4 B 8 LEU B 103 GLU B 106 1 O LEU B 103 N THR B 19 SHEET 5 B 8 ILE B 131 SER B 134 1 O ALA B 133 N GLU B 106 SHEET 6 B 8 PHE B 154 HIS B 158 1 O ALA B 155 N PHE B 132 SHEET 7 B 8 LEU B 168 LYS B 173 -1 O GLU B 170 N HIS B 158 SHEET 8 B 8 HIS B 195 LYS B 200 1 O VAL B 197 N VAL B 171 CISPEP 1 ASN A 161 PRO A 162 0 -0.46 CISPEP 2 ASN B 161 PRO B 162 0 -0.26 SITE 1 AC1 13 GLY A 24 LEU A 25 MET A 26 ASP A 45 SITE 2 AC1 13 GLN A 46 ALA A 107 ILE A 108 GLN A 110 SITE 3 AC1 13 ASN A 135 SER A 137 ASN A 161 HOH A 888 SITE 4 AC1 13 HOH A 945 SITE 1 AC2 13 GLY B 24 LEU B 25 MET B 26 ASP B 45 SITE 2 AC2 13 GLN B 46 ALA B 107 ILE B 108 VAL B 109 SITE 3 AC2 13 GLN B 110 LYS B 115 ASN B 135 SER B 137 SITE 4 AC2 13 HOH B 841 CRYST1 50.020 85.950 168.505 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019992 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011635 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005935 0.00000